Erratum: Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction (Circulation (2016) 133 (1484-1497) DOI: 10.1161/CIRCULATIONAHA.115.020143);Selective Stimulation of Cardiac Lymphangiogenesis Reduces Myocardial Edema and Fibrosis Leading to Improved Cardiac Function Following Myocardial Infarction

Circulation

Volumn 133, Issue 15, 2016, Pages 1484-1497

  Henri, Orianne ^a,b   Pouehe, Chris ^a,b   Houssari, Mahmoud ^a,b   Galas, Ludovic ^a,b   Nicol, Lionel ^a,b   Edwards Lévy, Florence ^c   Henry, Jean Paul ^a,b   Dumesnil, Anais ^a,b   Boukhalfa, Inès ^a,b   Banquet, Sébastien ^a,b   Schapman, Damien ^a,b   Thuillez, Christian ^a,b,d   Richard, Vincent ^a,b   Mulder, Paul ^a,b   Brakenhielm, Ebba ^a,b  

^a INSERM   (France)

^b UNIVERSITY OF ROUEN   (France)

^c Institut Fédératif Recherche 53   (France)

^d ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

edema; edema, cardiac; fibrosis; heart failure; lymphatic vessels; therapeutics; vascular endothelial growth factor C; ventricular remodeling

Indexed keywords

VASCULOTROPIN A; VASCULOTROPIN C; VASCULOTROPIN RECEPTOR 3; VASCULAR ENDOTHELIAL GROWTH FACTOR A, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIAC LYMPHANGIOGENESIS; CARDITIS; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CORONARY ARTERY OCCLUSION; FLUID BALANCE; HEART CONTRACTION; HEART EDEMA; HEART FAILURE; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE FIBROSIS; LEFT CORONARY ARTERY; LYMPHANGIOGENESIS; MALE; MEMBRANE MICROPARTICLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE CELL; AMINO ACID SUBSTITUTION; ANIMAL; CARDIAC MUSCLE; CHEMISTRY; COMPLICATION; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; EDEMA; FIBROSIS; HEART; LYMPH VESSEL; LYMPHOGRAPHY; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; PRECLINICAL STUDY; RADIOGRAPHY; THREE DIMENSIONAL IMAGING; WISTAR RAT;

AMINO ACID SUBSTITUTION; ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; EDEMA; FIBROSIS; HEART; IMAGING, THREE-DIMENSIONAL; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; LYMPHOGRAPHY; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; RATS; RATS, WISTAR; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 84960158338     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIR.0000000000001023     Document Type: Erratum

References (56)

1. Shore LR, The lymphatic drainage of the human heart. J Anat 1929 63 pt 3 291 313
2. Bradham RR, Parker EF, Barrington BA Jr, Webb CM, Stallworth JM, The cardiac lymphatics. Ann Surg 1970 171 899 902
3. Miller AJ, The grossly invisible and generally ignored lymphatics of the mammalian heart. Med Hypotheses 2011 76 604 606. doi: 10.1016/j.mehy.2011.01.012
4. Levick JR, Michel CC, Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 2010 87 198 210. doi: 10.1093/cvr/cvq062
5. Kline IK, Miller AJ, Katz LN, Cardiac lymph flow impairment and myocardial fibrosis. Effects of chronic obstruction in dogs. Arch Pathol 1963 76 424 433
6. Ludwig LL, Schertel ER, Pratt JW, McClure DE, Ying AJ, Heck CF, Myerowitz PD, Impairment of left ventricular function by acute cardiac lymphatic obstruction. Cardiovasc Res 1997 33 164 171
7. Cui Y, The role of lymphatic vessels in the heart. Pathophysiology 2010 17 307 314. doi: 10.1016/j.pathophys.2009.07.006
8. Mehlhorn U, Geissler HJ, Laine GA, Allen SJ, Myocardial fluid balance. Eur J Cardiothorac Surg 2001 20 1220 1230
9. Li J, Brown LF, Hibberd MG, Grossman JD, Morgan JP, Simons M, VEGF, flk-1, and flt-1 expression in a rat myocardial infarction model of angiogenesis. Am J Physiol 1996 270 5 pt 2 H1803 H1811
10. Weis S, Shintani S, Weber A, Kirchmair R, Wood M, Cravens A, McSharry H, Iwakura A, Yoon YS, Himes N, Burstein D, Doukas J, Soll R, Losordo D, Cheresh D, Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction. J Clin Invest 2004 113 885 894. doi: 10.1172/JCI20702
11. Weis SM, Cheresh DA, Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005 437 497 504. doi: 10.1038/nature03987
12. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo JL, Libby P, Weissleder R, Pittet MJ, The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007 204 3037 3047. doi: 10.1084/jem.20070885
13. Barbay V, Houssari M, Mekki M, Banquet S, Edwards-Lévy F, Henry JP, Dumesnil A, Adriouch S, Thuillez C, Richard V, Brakenhielm E, Role of M2-like macrophage recruitment during angiogenic growth factor therapy. Angiogenesis 2015 18 191 200. doi: 10.1007/s10456-014-9456-z
14. Mann DL, Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 2002 91 988 998
15. Zawieja DC, Greiner ST, Davis KL, Hinds WM, Granger HJ, Reactive oxygen metabolites inhibit spontaneous lymphatic contractions. Am J Physiol 1991 260 6 pt 2 H1935 H1943
16. Aldrich MB, Sevick-Muraca EM, Cytokines are systemic effectors of lymphatic function in acute inflammation. Cytokine 2013 64 362 369. doi: 10.1016/j.cyto.2013.05.015
17. Nilsson JC, Nielsen G, Groenning BA, Fritz-Hansen T, Sondergaard L, Jensen GB, Larsson HB, Sustained postinfarction myocardial oedema in humans visualised by magnetic resonance imaging. Heart 2001 85 639 642
18. Manrique A, Gerbaud E, Derumeaux G, Cribier A, Bertrand D, Lebon A, Dacher JN, Cardiac magnetic resonance demonstrates myocardial oedema in remote tissue early after reperfused myocardial infarction. Arch Cardiovasc Dis 2009 102 633 639. doi: 10.1016/j.acvd.2009.05.006
19. Alitalo K, Carmeliet P, Molecular mechanisms of lymphangiogenesis in health and disease. Cancer Cell 2002 1 219 227
20. Alitalo K, The lymphatic vasculature in disease. Nat Med 2011 17 1371 1380. doi: 10.1038/nm.2545
21. Zheng W, Aspelund A, Alitalo K, Lymphangiogenic factors, mechanisms, and applications. J Clin Invest 2014 124 878 887. doi: 10.1172/JCI71603
22. Dashkevich A, Bloch W, Antonyan A, Fries JU, Geissler HJ, Morphological and quantitative changes of the initial myocardial lymphatics in terminal heart failure. Lymphat Res Biol 2009 7 21 27. doi: 10.1089/lrb.2008.1010
23. Kholova I, Dragneva G, Cermakova P, Laidinen S, Kaskenpaa N, Hazes T, Cermakova E, Steiner I, Yla-Herttuala S, Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol-rich and calcified atherosclerotic lesions. Eur J Clin Invest 2010 41 487 497
24. Norrmén C, Tammela T, Petrova TV, Alitalo K, Biological basis of therapeutic lymphangiogenesis. Circulation 2011 123 1335 1351. doi: 10.1161/CIRCULATIONAHA.107.704098
25. Huggenberger R, Ullmann S, Proulx ST, Pytowski B, Alitalo K, Detmar M, Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp Med 2010 207 2255 2269. doi: 10.1084/jem.20100559
26. Lähteenvuo M, Honkonen K, Tervala T, Tammela T, Suominen E, Lähteenvuo J, Kholová I, Alitalo K, Ylä-Herttuala S, Saaristo A, Growth factor therapy and autologous lymph node transfer in lymphedema. Circulation 2011 123 613 620. doi: 10.1161/CIRCULATIONAHA.110.965384
27. Banquet S, Gomez E, Nicol L, Edwards-Lévy F, Henry JP, Cao R, Schapman D, Dautreaux B, Lallemand F, Bauer F, Cao Y, Thuillez C, Mulder P, Richard V, Brakenhielm E, Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure. Circulation 2011 124 1059 1069. doi: 10.1161/CIRCULATIONAHA.110.010264
28. Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, Renet S, Lerebours G, Mahlberg-Gaudin F, Thuillez C, Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation 2004 109 1674 1679. doi: 10.1161/01.CIR.0000118464.48959.1C
29. Luo Z, Diaco M, Murohara T, Ferrara N, Isner JM, Symes JF, Vascular endothelial growth factor attenuates myocardial ischemia-reperfusion injury. Ann Thorac Surg 1997 64 993 998
30. Ratajska A, Gula G, Flaht-Zabost A, Czarnowska E, Ciszek B, Jankowska-Steifer E, Niderla-Bielinska J, Radomska-Lesniewska D, Comparative and developmental anatomy of cardiac lymphatics. ScientificWorldJournal 2014 2014 183170. doi: 10.1155/2014/183170
31. Kataru RP, Jung K, Jang C, Yang H, Schwendener RA, Baik JE, Han SH, Alitalo K, Koh GY, Critical role of CD11b+ macrophages and VEGF in inflammatory lymphangiogenesis, antigen clearance, and inflammation resolution. Blood 2009 113 5650 5659. doi: 10.1182/blood-2008-09-176776
32. Wiig H, Schröder A, Neuhofer W, Jantsch J, Kopp C, Karlsen TV, Boschmann M, Goss J, Bry M, Rakova N, Dahlmann A, Brenner S, Tenstad O, Nurmi H, Mervaala E, Wagner H, Beck FX, Müller DN, Kerjaschki D, Luft FC, Harrison DG, Alitalo K, Titze J, Immune cells control skin lymphatic electrolyte homeostasis and blood pressure. J Clin Invest 2013 123 2803 2815. doi: 10.1172/JCI60113
33. Joukov V, Kumar V, Sorsa T, Arighi E, Weich H, Saksela O, Alitalo K, A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem 1998 273 6599 6602
34. Burton JB, Johnson M, Sato M, Koh SB, Mulholland DJ, Stout D, Chatziioannou AF, Phelps ME, Wu H, Wu L, Adenovirus-mediated gene expression imaging to directly detect sentinel lymph node metastasis of prostate cancer. Nat Med 2008 14 882 888. doi: 10.1038/nm.1727
35. Nykänen AI, Sandelin H, Krebs R, Keränen MA, Tuuminen R, Kärpänen T, Wu Y, Pytowski B, Koskinen PK, Ylä-Herttuala S, Alitalo K, Lemström KB, Targeting lymphatic vessel activation and CCL21 production by vascular endothelial growth factor receptor-3 inhibition has novel immunomodulatory and antiarteriosclerotic effects in cardiac allografts. Circulation 2010 121 1413 1422. doi: 10.1161/CIRCULATIONAHA.109.910703
36. Davis KL, Laine GA, Geissler HJ, Mehlhorn U, Brennan M, Allen SJ, Effects of myocardial edema on the development of myocardial interstitial fibrosis. Microcirculation 2000 7 269 280
37. Moriwaki H, Stempien-Otero A, Kremen M, Cozen AE, Dichek DA, Overexpression of urokinase by macrophages or deficiency of plasminogen activator inhibitor type 1 causes cardiac fibrosis in mice. Circ Res 2004 95 637 644. doi: 10.1161/01.RES.0000141427.61023.f4
38. McKimmie CS, Singh MD, Hewit K, Lopez-Franco O, Le Brocq M, Rose-John S, Lee KM, Baker AH, Wheat R, Blackbourn DJ, Nibbs RJ, Graham GJ, An analysis of the function and expression of D6 on lymphatic endothelial cells. Blood 2013 121 3768 3777. doi: 10.1182/blood-2012-04-425314
39. Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Tanaka M, Shimokawa R, Kimura-Matsumoto M, Morita H, Sato S, Kamata I, Ishii T, Lymphangiogenesis in myocardial remodelling after infarction. Histopathology 2007 51 345 353. doi: 10.1111/j.1365-2559.2007.02785.x
40. Sun QN, Wang YF, Guo ZK, Reconstitution of myocardial lymphatic vessels after acute infarction of rat heart. Lymphology 2012 45 80 86
41. Klotz L, Norman S, Vieira JM, Masters M, Rohling M, Dubé KN, Bollini S, Matsuzaki F, Carr CA, Riley PR, Cardiac lymphatics are heterogeneous in origin and respond to injury. Nature 2015 522 62 67. doi: 10.1038/nature14483
42. Laine GA, Allen SJ, Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res 1991 68 1713 1721
43. Dongaonkar RM, Stewart RH, Geissler HJ, Laine GA, Myocardial microvascular permeability, interstitial oedema, and compromised cardiac function. Cardiovasc Res 2010 87 331 339. doi: 10.1093/cvr/cvq145
44. Wick N, Haluza D, Gurnhofer E, Raab I, Kasimir MT, Prinz M, Steiner CW, Reinisch C, Howorka A, Giovanoli P, Buchsbaum S, Krieger S, Tschachler E, Petzelbauer P, Kerjaschki D, Lymphatic precollectors contain a novel, specialized subpopulation of podoplanin low, CCL27-expressing lymphatic endothelial cells. Am J Pathol 2008 173 1202 1209. doi: 10.2353/ajpath.2008.080101
45. Lutter S, Xie S, Tatin F, Makinen T, Smooth muscle-endothelial cell communication activates Reelin signaling and regulates lymphatic vessel formation. J Cell Biol 2012 197 837 849. doi: 10.1083/jcb.201110132
46. Taira A, Morishita Y, Arikawa K, Murata K, Hamada Y, Akita H, Flow velocity of cardiac lymph and contractility of the heart: an experimental study. Ann Thorac Surg 1977 23 230 234
47. Mehlhorn U, Davis KL, Burke EJ, Adams D, Laine GA, Allen SJ, Impact of cardiopulmonary bypass and cardioplegic arrest on myocardial lymphatic function. Am J Physiol 1995 268 1 pt 2 H178 H183
48. Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu JS, Isner JM, Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 1998 153 381 394. doi: 10.1016/S0002-9440(10)65582-4
49. Losordo DW, Vale PR, Hendel RC, Milliken CE, Fortuin FD, Cummings N, Schatz RA, Asahara T, Isner JM, Kuntz RE, Phase placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002 105 2012 2018
50. Joukov V, Sorsa T, Kumar V, Jeltsch M, Claesson-Welsh L, Cao Y, Saksela O, Kalkkinen N, Alitalo K, Proteolytic processing regulates receptor specificity and activity of VEGF-C. EMBO J 1997 16 3898 3911. doi: 10.1093/emboj/16.13.3898
51. Cao Y, Linden P, Farnebo J, Cao R, Eriksson A, Kumar V, Qi JH, Claesson-Welsh L, Alitalo K, Vascular endothelial growth factor C induces angiogenesis in vivo. Proc Natl Acad Sci U S A 1998 95 14389 14394
52. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J, Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 2004 94 664 670. doi: 10.1161/01.RES.0000118600.91698.BB
53. Tammela T, Saaristo A, Holopainen T, Lyytikkä J, Kotronen A, Pitkonen M, Abo-Ramadan U, Ylä-Herttuala S, Petrova TV, Alitalo K, Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med 2007 13 1458 1466. doi: 10.1038/nm1689
54. Nagy JA, Vasile E, Feng D, Sundberg C, Brown LF, Detmar MJ, Lawitts JA, Benjamin L, Tan X, Manseau EJ, Dvorak AM, Dvorak HF, Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis. J Exp Med 2002 196 1497 1506
55. Cao Y, Therapeutic angiogenesis for ischemic disorders: what is missing for clinical benefits? Discov Med 2010 9 179 184
56. Cao R, Ji H, Feng N, Zhang Y, Yang X, Andersson P, Sun Y, Tritsaris K, Hansen AJ, Dissing S, Cao Y, Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis. Proc Natl Acad Sci U S A 2012 109 15894 15899. doi: 10.1073/pnas.1208324109